Legendary Stock Picker: “Forget Nvidia, Buy This Instead”

Eric Fry will show you how “the next $1 trillion AI stock” could hand you up to 40 years of Nvidia gains in the coming months.

Tue, May 21 at 7:00PM ET
 
 
 
 
Biotech Stocks Icon

Biotech Stocks

Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

Recent Biotech Stocks Articles

Why Is CVRx (CVRX) Stock Down 32% Today?

CVRx stock is falling hard on Wednesday after the company posted EPS and revenue misses in its earnings report for Q1 2024.

3 Top Penny Stocks to Buy for Explosive Returns: April Edition

Some of the top penny stocks to buy can be rewarding, such as these three that investors may want to grab now.

7 Safe Haven Stocks That Can Withstand the Market’s Worst Meltdowns

Safe haven stocks offer stability even during market fall in communication, financials, healthcare, energy and consumer staples.

Stock Market Crash Warning: Don’t Get Caught Holding These 3 Biotech Stocks

As the stock market corrects, focusing on stable investments is crucial. This is why you should steer clear of these biotech stocks to avoid.

Why Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today?

Cyclacel Pharmaceuticals stock is up on Tuesday with heavy trading of CYCC shares after the company withdrew a public offering.

Is a Giant Short Squeeze in Ginkgo Bioworks (DNA) Stock?

DNA stock is up 15% today for little reason, fueling speculation that Ginkgo Bioworks may be in the midst of a short squeeze.

Why Is Deciphera Pharmaceuticals (DCPH) Stock Up 72% Today?

Deciphera Pharmaceuticals stock is up on Monday after DCPH investors learned of a $2.4 billion acquisition deal with ONO Pharmaceutical.

Why Is Koninklijke Philips (PHG) Stock Up 41% Today?

Koninklijke Philips stock is up on Monday as investors in PHG react to the company reaching a $1.1 billion lawsuit settlement.

3 Dividend Stocks to Buy on the Dip: April 2024

At first glance, the concept of dividend stocks to buy on the dip might clash with your instincts. Right now, the combination of robust employment…

The Top 3 Biotech Stocks to Buy in April 2024

Learn about the top three biotech stocks to take advantage of these companies' promising futures and pharmaceutical advances.

Why Is Biodexa (BDRX) Up 70% Today?

Oncology specialist Biodexa inked a compelling licensing deal to treat a serious disease, and BDRX stock popped sharply higher.

3 Biotech Stocks to Buy on the Dip: April 2024

If you follow Warren Buffett’s advice of being greedy when others are fearful, then it probably makes sense to consider biotech stocks to buy on…

3 Contrarian Investments to Make Now for Massive Upside Potential

A combination of nervous investors and highly aggressive short sellers has made many contrarian investments quite attractive. 

Why Is OptiNose (OPTN) Stock Up 12% Today?

OptiNose stock is taking off on Thursday alongside an update on XHANCE that brings heavy trading to OPTN shares this morning.

7 Blue-Chip Stocks to Buy on the Dip: April 2024

Each of these seven blue-chip stocks to buy on the dip offers high quality at a more-than-reasonable price.

3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition

Many fortunes have been made with a fortuitous investment in a biotech stock at the right time. That time might be now.

Which Companies Will Join the Trillion-Dollar Team in 2024? Our 3 Best Guesses

Explore the dynamics of money-maker stocks in 2024, which are fueled by AI advancements and robust economic growth.

Dirt-Cheap Delights: 3 Discounted Stocks That Could Triple by 2026

Investors looking for discounted stocks to reap big gains by 2026 might be interested in these three top-notch picks.

3 Biotech Stocks With Skyrocketing Potential: April 2024

These three biotech stocks, with robust fundamentals and long-term prospects represent the sector’s finest at this time.